SOURCE: Vivione Biosciences Inc.

Vivione Biosciences

February 25, 2015 07:00 ET

Vivione Biosciences Announces Successful Field Deployment of RAPID-B With Greene's Energy

DALLAS, TX--(Marketwired - February 25, 2015) - Vivione Biosciences Inc. ("Vivione") (TSX VENTURE: VBI), announced today the successful field deployment of its proprietary bacterial detection platform, RAPID-B with Greene's Energy Group, LLC. Greene's utilized Vivione's RAPID-B system to detect and enumerate bacteria in oil field flow-back water samples before and after anti-microbial treatments were administered. Within 20 minutes of testing, RAPID-B provided Greene's with relevant data on the impact their antimicrobial treatments had on reducing the viable bacteria in the water. The real time data allowed Greene's to immediately optimize their treatment and provide their customer, one of the large independent Energy and Production companies, with a level of service that previous technologies could not provide.

Brandon Faulk of Greene's Energy Group's Water Treatment Services division commented, "The reason we chose Vivione's RAPID-B platform to provide us with additional data is due to the precision their equipment brings to the outdated diagnostic tools in the oil & gas industry when it comes to determining bacterial counts. Vivione's technology has allowed Greene's Water Treatment Services division to determine real time bacterial counts when it is needed most. The data has allowed us to improve and fine tune our water treatment efficiencies while onsite that would not have been possible with previous technologies in the given time frame." 

The potential beneficial use of produced waters is an area of expanding interest in the oil and gas exploration and production industry, particularly in areas with limited water resources. Oilfield service companies such as Greene's are charged with the management, filtration and reuse of these waters. 

In order to effectively manage and treat oilfield production waters it is necessary to first analyze the water content to determine what treatment modalities are necessary.

"We believe the RAPID-B system gives water treatment companies the best possible tool for determining the effectiveness of a treatment protocol. There are absolutely no competing products in the oil & gas space that can provide this level of rapid information to the producer/service provider," according to Kevin Kuykendall, Vivione's CEO. Kuykendall continued, "The production of oil and gas from unconventional formations has surpassed conventional production in the United States and abroad. In the U.S. alone there are over 700,000 hydraulic fracturing stages annually with numerous water treatments and tests required for every stage. We see this as a great opportunity to expand our market presence outside of Food Safety and Clinical Diagnostics while promoting green chemistry to the industry with the information it needs to foster evidence-based, scientific approaches in the pursuit of more sustainable practices in water management and hydraulic fracturing."

About Greene's

Greene's Energy Group, LLC is a leading provider of integrated testing, rentals and specialty services for drilling, production, pipeline, and construction & process operations. Greene's offers tools and services to improve productivity onshore and offshore. Serving customers in drilling, production, pipeline, rig and platform construction, well intervention and process industries, the company has a top-notch reputation in the energy service arena. Greene's experience, knowledge, responsiveness and attention to safety have made it an industry leader. The company strives for excellence in safety, products and staff knowledge. This mission guides the company's growth and expansion plans for all of its energy-service businesses.

About Vivione

Vivione is a TSX Venture Exchange listed biosciences company focused on the commercialization of its proprietary RAPID-B platform; an integrated platform of hardware, software and reagents that quickly and accurately identify, quantify and qualify bacteria and other pathogens in key food & water safety, clinical, industrial and oil & gas environments. For more information, visit www.VivioneBiosciences.com.

Cautionary Statements
This news release contains "forward-looking statements" within the meaning of applicable securities laws. Although Vivione believes that the expectations reflected in its forward-looking statements are reasonable, such statements have been based on factors and assumptions concerning future events that may prove to be inaccurate. These factors and assumptions are based upon currently available information to Vivione. Such statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. This news release contains forward-looking information relating to the commercialization and the development of the RAPID-B platform. Readers are cautioned to not place undue reliance on forward-looking statements. The statements in this news release are made as of the date of this news release and, except as required by applicable law, Vivione does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. Vivione undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of Vivione, or its financial or operating results or (as applicable), their securities.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.

Contact Information